#United States #New York #Gross Law Firm #Applied Therapeutics #APLT

Applied Therapeutics Shareholder Notice

In a recent announcement, The Gross Law Firm is notifying shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT) about an urgent opportunity to discuss their rights before February 18, 2025. This communication particularly targets individuals who acquired shares during the specified class period, which spans from January 3, 2024, to December 2, 2024.

The impetus behind this notice stems from alarming developments within the company. On November 27, 2024, Applied Therapeutics revealed that it had received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) concerning its New Drug Application (NDA) for govorestat, its lead drug candidate. This CRL indicated significant deficiencies that halted the approval process, leading to a drastic fall in the company's stock price.

The aftermath of this news was swift and severe. Prior to the announcement, shares of Applied Therapeutics closed at $10.21 on November 26, 2024. Following the CRL disclosure, the stock plummeted to $8.57 on the following day and further nosedived to $1.75 by December 2, 2024. Overall, this represented an astonishing loss of over 80% in market value. Subsequent to this, the firm's announcement of receiving a warning letter from the FDA on December 2 concerning underlying clinical trial issues further exacerbated investor concerns, causing the share price to dip even more.

Given these circumstances, shareholders who experienced financial losses are strongly encouraged to connect with The Gross Law Firm for guidance on possibly being appointed as lead plaintiffs in a class action lawsuit. Engaging with the firm does not require one to have lead plaintiff status to recover potential losses.

Why Should You Act Now?

The deadline for registering and asserting your rights in this matter is February 18, 2025. By contacting the Gross Law Firm, you can ensure that you are kept informed of the status of the case through a specially designed monitoring system.

It is crucial that affected shareholders do not delay in their outreach. The Gross Law Firm is a nationally recognized entity dedicated to safeguarding the rights of investors suffering losses from deceitful practices in the business realm. They are committed to holding companies accountable and recovering losses incurred due to misleading information that artificially inflated stock prices.

Interested parties can register for this class action by visiting the following link: Register Here.

For direct inquiries, you can reach The Gross Law Firm at:

• - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Conclusion

As the situation develops, it is imperative for shareholders of Applied Therapeutics to remain proactive. By aligning with The Gross Law Firm, investors can navigate this turbulent period with greater awareness and support. Without prompt action, shareholders may miss out on their chance to recover losses in the wake of these troubling developments.